Online citations, reference lists, and bibliographies.

PROGRESS: Prevention Of Recurrent Stroke

H. Arima, J. Chalmers
Published 2011 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
J Clin Hypertens (Greenwich). 2011;13;693–702. ©2011 Wiley Periodicals, Inc.
This paper references
10.1212/WNL.53.9.1948
Cognitive decline in individuals with high blood pressure
C. Tzourio (1999)
10.1161/CIRCULATIONAHA.106.622464
Relationship Between Blood Pressure and Stroke Recurrence in Patients With Intracranial Arterial Stenosis
T. Turan (2007)
10.1161/01.STR.0000166048.35740.a9
Morbidity and Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary Prevention: Principal Results of a Prospective Randomized Controlled Study (MOSES)
J. Schrader (2005)
10.1097/01.HJH.0000052492.18130.07
Blood pressure and cardiovascular disease in the Asia Pacific region
C. Lawes (2003)
10.1056/NEJMoa1001286
Effects of intensive blood-pressure control in type 2 diabetes mellitus.
W. Cushman (2010)
Dementia after ischemic stroke: a population-based study in
E Kokmen (1960)
Effects of blood pressure lowering on major vascular events among patients with isolated diastolic hypertension: the PROGRESS trial
H Arima (2011)
10.32388/j77lak
[Transient ischemic attack].
K. Ottes (2009)
10.1097/01.hjh.0000226212.34055.86
Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial
H. Arima (2006)
10.1056/NEJM200001203420301
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.
S. Yusuf (2000)
Dementia after ischemic stroke : a population - based study in Rochester , Minnesota ( 1960 - 1984 )
T Pohjasvaara (1996)
Preventing Chronic Disease: a Vital Investment. Geneva: World Health Organization
(2005)
10.1016/S0140-6736(08)61242-8
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.
S. Yusuf (2008)
10.1161/STROKEAHA.108.540633
Severe Cerebral White Matter Hyperintensities Predict Severe Cognitive Decline in Patients With Cerebrovascular Disease History
C. Dufouil (2009)
10.1161/01.STR.0000090125.28466.E2
Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association.
R. Adams (2003)
Post-stroke antihypertensive treatment study. A preliminary result.
Pats (1995)
10.1093/EURHEARTJ/EHM236
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
G. Mancia (2007)
10.1038/hr.2009.139
Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature
L. Liu (2009)
Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-53.
S. Yusuf (2000)
10.1161/01.STR.28.12.2557
Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators.
F. Gueyffier (1997)
10.1161/01.STR.0000106480.76217.6F
Effects of a Perindopril-Based Blood Pressure–Lowering Regimen on the Risk of Recurrent Stroke According to Stroke Subtype and Medical History: The PROGRESS Trial
N. Chapman (2004)
10.1038/ki.2008.5
Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial.
T. Ninomiya (2008)
10.1161/01.STR.0000094424.38761.56
Relationship Between Blood Pressure and Stroke Risk in Patients With Symptomatic Carotid Occlusive Disease
P. Rothwell (2003)
10.1161/CIRCULATIONAHA.104.501163
Effects of Blood Pressure Lowering on Cerebral White Matter Hyperintensities in Patients With Stroke: The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy
C. Dufouil (2005)
Effect of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomized controlled trial: The Telmisartan Randomised Assessment Study in ACE intolerant subjects with cardiovascular Disease (TRANSCEND)
W. Ahmad (2008)
10.1016/S0140-6736(96)90608-X
15-year longitudinal study of blood pressure and dementia
I. Skoog (1996)
Global burden of bloodpressure-related disease
C M Lawes (2001)
10.1161/01.STR.0000091397.81767.40
Effects of a Perindopril-Based Blood Pressure–Lowering Regimen on Disability and Dependency in 6105 Patients With Cerebrovascular Disease: A Randomized Controlled Trial
M. Fransen (2003)
10.1016/S0140-6736(02)11911-8
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.
S. Lewington (2002)
10.1161/01.STR.0000165926.74213.e3
Recurrent Stroke Risk Is Higher Than Cardiac Event Risk After Initial Stroke/Transient Ischemic Attack
D. Brown (2005)
Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study
C Dufouil (2005)
10.1161/01.STR.28.4.785
Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort.
T. Pohjasvaara (1997)
10.1016/S0140-6736(03)14739-3
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.
F. Turnbull (2003)
Blood pressure and cardiovascular diseases in the Asia - Pacific region
A Rodgers (2003)
10.1161/STROKEAHA.109.563932
Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy: The PROGRESS Trial
H. Arima (2010)
10.1097/01.hjh.0000431740.32696.cc
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
G. Mancia (2013)
10.1097/HJH.0B013E3281FC975A
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
G. Mancia (2007)
10.1161/01.STR.0000181115.59173.42
Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack.
H. Arima (2005)
10.1007/s10198-008-0108-3
An economic evaluation of a perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event
M. Tavakoli (2008)
10.1097/HJH.0b013e328333b009
Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial
H. Arima (2010)
Dementia after ischemic stroke: a population-based study
E Kokmen (1960)
10.1016/S0140-6736(08)60655-8
Global burden of blood-pressure-related disease, 2001
C. Lawes (2008)
10.1161/STROKEAHA.110.606764
Effects of Blood Pressure Lowering on Major Vascular Events Among Patients With Isolated Diastolic Hypertension: The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) Trial*
H. Arima (2011)
10.1016/S0140-6736(02)08089-3
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
B. Dahlöf (2002)
[Should beta-blockers remain first choice in the treatment of primary hypertension?].
A. Pose-Reino (2007)
10.1212/WNL.46.1.154
Dementia after ischemic stroke
E. Kokmen (1996)
Post-stroke antihypertensive treatment study. A preliminary result
Pats-Collaborating-Group- (1995)
10.1161/HYPERTENSIONAHA.109.140624
Impact of Blood Pressure Lowering on Cardiovascular Outcomes in Normal Weight, Overweight, and Obese Individuals: The Perindopril Protection Against Recurrent Stroke Study Trial
S. Czernichow (2010)
10.1161/01.HYP.0000107251.49515.C2
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
A. Chobanian (2003)
10.1097/00004872-200403000-00030
Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region
A. Rodgers (2004)
10.1080/08037050510008823
The Study on COgnition and Prognosis in the Elderly (SCOPE) – Major CV events and stroke in subgroups of patients
P. Trenkwalder (2005)
World Health Organization. The Atlas of Heart Disease and Stroke. Geneva: World Health Organization
(2004)
10.1016/S0195-668X(02)00804-7
Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease.
V. Chaturvedi (2003)
, eprosartan compared with nitrendipine for secondary prevention : principal results of a prospective randomised controlled study ( MOSES )
P Trenkwalder (2005)
Recurrent
DL Brown (2004)
10.1016/S0140-6736(05)67185-1
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled tri
B. Dahlöf (2005)
10.1136/BMJ.313.7050.147
Blood pressure and risk of stroke in patients with cerebrovascular disease
A. Rodgers (1996)
10.1161/01.STR.0000221212.36860.c9
Prior Events Predict Cerebrovascular and Coronary Outcomes in the PROGRESS Trial
H. Arima (2006)
10.1056/NEJMoa0804593
Telmisartan to prevent recurrent stroke and cardiovascular events.
S. Yusuf (2008)
10.1161/01.STR.0000091397.81767.40
Effects of a Perindopril-Based Blood Pressure–Lowering Regimen on Disability and Dependency in 6105 Patients With Cerebrovascular Disease A Randomized Controlled Trial
Progress (2003)
10.1080/08037050410029605
Reductions in the risks of recurrent stroke in patients with and without diabetes: The PROGRESS Trial
K. Berthet (2004)
Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack
S. MacMahon (2001)
10.1001/ARCHINTE.163.9.1069
Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.
C. Tzourio (2003)
risk in patients with symptomatic carotid occlusive disease
J Schrader (2003)
risk is higher than cardiac event risk after initial stroke ⁄ transient ischemic attack
H Arima (2005)
10.1016/S0140-6736(02)11911-8
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
Prospective Studies Collaboration (2002)
10.1007/S11886-001-0034-9
The Heart Outcomes Prevention Evaluation Study.
Kukin Ml (2001)
10.1681/ASN.2007020256
Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS study.
V. Perkovic (2007)



This paper is referenced by
An investigation of the post-exercise hypotensive response following an acute bout of aquatic and overground treadmill walking in people post-stroke
Byron Lai (2014)
10.1371/journal.pone.0080690
Glycated Hemoglobin Independently Predicts Stroke Recurrence within One Year after Acute First-Ever Non-Cardioembolic Strokes Onset in A Chinese Cohort Study
S. Wu (2013)
10.1007/s11096-018-0745-2
Evaluation of a hypertension-based patient education program in a stroke center
Nesrine Ben Nasr (2018)
10.1093/ndt/gfx363
Chronic kidney disease and stroke: more observations but no trials.
Adrian Covic (2018)
10.1038/hr.2014.20
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014)
K. Shimamoto (2014)
10.1111/jch.13194
Post‐stroke hypertension control and receipt of health care services among veterans
Dhanashri D Kohok (2018)
10.1136/practneurol-2014-000952
Cerebral amyloid angiopathy: amyloid spells and cortical superficial siderosis
Rebecca Coates (2014)
10.1253/CIRCJ.CJ-16-0692
Calcium-Channel Blockers and Dementia Risk in Older Adults - National Health Insurance Service - Senior Cohort (2002-2013).
Deri Hwang (2016)
10.5005/JP-JOURNALS-10043-0034
Small Vessel Disease of the Brain and Stroke: Association with Clinic and Ambulatory Blood Pressure
Puneet Gupta (2016)
10.1007/978-3-319-45345-3_31
Unpuzzling the Comorbid Type 2 Diabetes and Hypertension-Related Cognitive Dysfunction and Stroke
Inês Sebastião (2017)
10.1002/9781118492390.CH17
Preventing recurrent stroke and other serious vascular events
C. Halabi (2019)
10.1038/s41440-019-0284-9
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
S. Umemura (2019)
10.1001/jamaneurol.2017.5153
Effect of Standard vs Intensive Blood Pressure Control on Cerebral Blood Flow in Small Vessel Disease
I. Croall (2018)
10.1212/WNL.0000000000006467
Racial differences in recurrent ischemic stroke risk and recurrent stroke case fatality
K. Albright (2018)
10.1024/0040-5930/A000679
Körperliche Inaktivität und chronische Erkrankungen
M. Burtscher (2015)
10.1161/STROKEAHA.112.651448
Effects of Blood Pressure Lowering on Intracranial and Extracranial Bleeding in Patients on Antithrombotic Therapy: The PROGRESS Trial
H. Arima (2012)
10.1080/07853890.2018.1564358
Use of antihypertensive medication after ischemic stroke in young adults and its association with long-term outcome
Myrna M E van Dongen (2019)
10.1007/s00701-016-2784-6
Predictors of aneurysmal rebleed before definitive surgical or endovascular management
Chirag M. Solanki (2016)
10.1007/s12035-015-9584-5
Angiotensin Receptor Blockade Modulates NFκB and STAT3 Signaling and Inhibits Glial Activation and Neuroinflammation Better than Angiotensin-Converting Enzyme Inhibition
S. Bhat (2015)
10.1007/978-3-319-45345-3_14
Effects of Neuroprotectants Before and After Stroke: Statins and Anti-hypertensives
R. Villa (2017)
10.5853/jos.2015.01102
Chronic Management of Hypertension after Stroke: The Role of Ambulatory Blood Pressure Monitoring
Luis Castilla-Guerra (2016)
10.2174/1570161115666171116151051
Stroke and Hypertension: An Appraisal from Pathophysiology to Clinical Practice.
Agata Buonacera (2019)
10.1177/1747493017706188
Telemedical strategies for the improvement of secondary prevention in patients with cerebrovascular events—A systematic review and meta-analysis
P. Kraft (2017)
10.1136/jnnp-2014-307856
Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial
H. Arima (2014)
10.1042/CS20120078
Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.
J. Saavedra (2012)
10.1161/CIRCOUTCOMES.113.000112
Trends in Vascular Risk Factor Treatment and Control in US Stroke Survivors: The National Health and Nutrition Examination Surveys (1999–2010)
N. Shah (2013)
10.17116/jnevro2018118091117
[Arterial hypertension, cognitive disorders and dementia: a view of a cardiologist].
O. Ostroumova (2018)
10.1179/1074935714Z.0000000016
Post-exercise hypotensive responses following an acute bout of aquatic and overground treadmill walking in people post-stroke: a pilot study
Byron Lai (2015)
Semantic Scholar Logo Some data provided by SemanticScholar